BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23865934)

  • 1. trans-[Ru(NO)Cl(cyclam)](PF6)2 and [Ru(NO)(Hedta)] incorporated in PLGA nanoparticles for the delivery of nitric oxide to B16-F10 cells: cytotoxicity and phototoxicity.
    Gomes AJ; Espreafico EM; Tfouni E
    Mol Pharm; 2013 Oct; 10(10):3544-54. PubMed ID: 23865934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. trans-[Ru(NO)(NH3)4(py)](BF4)3.H2O encapsulated in PLGA microparticles for delivery of nitric oxide to B16-F10 cells: Cytotoxicity and phototoxicity.
    Gomes AJ; Barbougli PA; Espreafico EM; Tfouni E
    J Inorg Biochem; 2008 Apr; 102(4):757-66. PubMed ID: 18215422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of an NO photoinduced releaser xerogel based on the controlled nitric oxide donor trans-[Ru(NO)Cl(cyclam)](PF6)2 (cyclam=1,4,8,11-tetraazacyclotetradecane).
    Ferreira KQ; Schneider JF; Nascente PA; Rodrigues-Filho UP; Tfouni E
    J Colloid Interface Sci; 2006 Aug; 300(2):543-52. PubMed ID: 16780861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer.
    Sun B; Ranganathan B; Feng SS
    Biomaterials; 2008 Feb; 29(4):475-86. PubMed ID: 17953985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodegradable polymeric system for cisplatin delivery: development, in vitro characterization and investigation of toxicity profile.
    Alam N; Khare V; Dubey R; Saneja A; Kushwaha M; Singh G; Sharma N; Chandan B; Gupta PN
    Mater Sci Eng C Mater Biol Appl; 2014 May; 38():85-93. PubMed ID: 24656356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT3 silencing in dendritic cells by siRNA polyplexes encapsulated in PLGA nanoparticles for the modulation of anticancer immune response.
    Alshamsan A; Haddadi A; Hamdy S; Samuel J; El-Kadi AO; Uludağ H; Lavasanifar A
    Mol Pharm; 2010 Oct; 7(5):1643-54. PubMed ID: 20804176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.
    Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J
    Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells.
    Mo L; Hou L; Guo D; Xiao X; Mao P; Yang X
    Int J Pharm; 2012 Oct; 436(1-2):815-24. PubMed ID: 22846410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivity, photolability, and computational studies of the ruthenium nitrosyl complex with a substituted cyclam fac-[Ru(NO)Cl2(κ3N4,N8,N11(1-carboxypropyl)cyclam)]Cl·H2O.
    Doro FG; Pepe IM; Galembeck SE; Carlos RM; da Rocha ZN; Bertotti M; Tfouni E
    Dalton Trans; 2011 Jun; 40(24):6420-32. PubMed ID: 21584321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium phosphate embedded PLGA nanoparticles: a promising gene delivery vector with high gene loading and transfection efficiency.
    Tang J; Chen JY; Liu J; Luo M; Wang YJ; Wei XW; Gao X; Wang BL; Liu YB; Yi T; Tong AP; Song XR; Xie YM; Zhao Y; Xiang M; Huang Y; Zheng Y
    Int J Pharm; 2012 Jul; 431(1-2):210-21. PubMed ID: 22561795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable PLGA85/15 nanoparticles as a delivery vehicle for Chlamydia trachomatis recombinant MOMP-187 peptide.
    Taha MA; Singh SR; Dennis VA
    Nanotechnology; 2012 Aug; 23(32):325101. PubMed ID: 22824940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
    Niu X; Zou W; Liu C; Zhang N; Fu C
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indocyanine green-loaded biodegradable nanoparticles: preparation, physicochemical characterization and in vitro release.
    Saxena V; Sadoqi M; Shao J
    Int J Pharm; 2004 Jul; 278(2):293-301. PubMed ID: 15196634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The macrocyclic effect and vasodilation response based on the photoinduced nitric oxide release from trans-[RuCl(tetraazamacrocycle)NO](2+).
    Oliveira Fde S; Ferreira KQ; Bonaventura D; Bendhack LM; Tedesco AC; Machado Sde P; Tfouni E; da Silva RS
    J Inorg Biochem; 2007 Feb; 101(2):313-20. PubMed ID: 17141326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A controlled NO-releasing compound: synthesis, molecular structure, spectroscopy, electrochemistry, and chemical reactivity of R,R,S,S-trans-[RuCl(NO)(cyclam)]2+(1,4,8,11-tetraazacyclotetradecane).
    Lang DR; Davis JA; Lopes LG; Ferro AA; Vasconcellos LC; Franco DW; Tfouni E; Wieraszko A; Clarke MJ
    Inorg Chem; 2000 May; 39(11):2294-300. PubMed ID: 12526488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y; Pan J; Feng SS
    Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sub-unit vaccine against S. aureus-mediated infections: set-up of nano-sized polymeric adjuvant.
    Colonna C; Dorati R; Conti B; Caliceti P; Genta I
    Int J Pharm; 2013 Aug; 452(1-2):390-401. PubMed ID: 23707885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of nitrosyl ruthenium complex-loaded lipid carriers for topical administration: improvement in skin stability and in nitric oxide release by visible light irradiation.
    Marquele-Oliveira F; Santana DC; Taveira SF; Vermeulen DM; de Oliveira AR; da Silva RS; Lopez RF
    J Pharm Biomed Anal; 2010 Dec; 53(4):843-51. PubMed ID: 20634015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a poly(d,l-lactic-co-glycolic acid) nanoparticle formulation of STAT3 inhibitor JSI-124: implication for cancer immunotherapy.
    Molavi O; Mahmud A; Hamdy S; Hung RW; Lai R; Samuel J; Lavasanifar A
    Mol Pharm; 2010 Apr; 7(2):364-74. PubMed ID: 20030320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.